학술논문
Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLC
Document Type
Short Communication
Author
Nassar, Amin H. ; Jayakrishnan, Ritujith ; Feng, Jamie ; Shepherd, Frances ; Adib, Elio ; Cheung, Justin M. ; Lin, Jessica J. ; Liu, Yufei ; Lin, Steven H. ; Parikh, Kaushal ; Sridhar, Arthi ; Shakya, Purnima ; Dilling, Thomas J. ; Kaldas, David ; Gray, Jhanelle E. ; Lobachov, Anastasiya ; Bar, Jair ; Luders, Heike ; Grohe, Christian ; Gupta, Shruti ; Leal, Ticiana ; Fitzgerald, Bailey ; Crowley, Fionnuala ; Fujiwara, Yu ; Marron, Thomas U. ; Wilgucki, Molly ; Reuss, Joshua ; Chen, Luxi ; Sankar, Kamya ; Aredo, Jacqueline V. ; Neal, Joel W. ; Wakelee, Heather A. ; Thummalapalli, Rohit ; Yu, Helena ; Whitaker, Ryan ; Velazquez, Ana ; Ragavan, Meera ; Cortellini, Alessio ; Kwiatkowski, David J. ; Naqash, Abdul Rafeh ; Goldberg, Sarah B. ; Kim, So Yeon
Source
In Journal of Thoracic Oncology January 2025 20(1):109-118
Subject
Language
ISSN
1556-0864
Abstract
@@@@Graphical abstract [Display omitted]